San Diego – With former Turing Pharmaceuticals AG CEO Martin Shkreli about to face trial on charges of securities fraud, Allergan PLC CEO Brent Saunders said – when BIO CEO and Chairman James Greenwood asked if Shkreli is the public face of the biopharmaceutical industry – that the industry doesn't have the luxury of pretending he is not.
During a "fireside chat" to open the BIO International Convention here, Saunders – who gained wide notice upon Allergan's unilateral...




